acetazolamide

Generic: acetazolamide

Labeler: zydus pharmaceuticals (usa) inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide
Generic Name acetazolamide
Labeler zydus pharmaceuticals (usa) inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acetazolamide 250 mg/1

Manufacturer
Zydus Pharmaceuticals (USA) Inc.

Identifiers & Regulatory

Product NDC 70710-1239
Product ID 70710-1239_b8ec300c-c64c-4a65-a101-66644f64f9f7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211069
Listing Expiration 2026-12-31
Marketing Start 2023-08-04

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707101239
Hyphenated Format 70710-1239

Supplemental Identifiers

RxCUI
197303 197304
UPC
0370710123819 0370710123918
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide (source: ndc)
Generic Name acetazolamide (source: ndc)
Application Number ANDA211069 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (70710-1239-1)
source: ndc

Packages (1)

70710-1239-1 100 TABLET in 1 BOTTLE (70710-1239-1)

Ingredients (1)

acetazolamide (250 mg/1)

Linked Drug Pages (1)

acetaZOLAMIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b8ec300c-c64c-4a65-a101-66644f64f9f7", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0370710123819", "0370710123918"], "unii": ["O3FX965V0I"], "rxcui": ["197303", "197304"], "spl_set_id": ["85e4d8f6-1e82-4068-a768-752287d4ccf2"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (70710-1239-1)", "package_ndc": "70710-1239-1", "marketing_start_date": "20230804"}], "brand_name": "acetaZOLAMIDE", "product_id": "70710-1239_b8ec300c-c64c-4a65-a101-66644f64f9f7", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "70710-1239", "generic_name": "acetaZOLAMIDE", "labeler_name": "Zydus Pharmaceuticals (USA) Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acetaZOLAMIDE", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "250 mg/1"}], "application_number": "ANDA211069", "marketing_category": "ANDA", "marketing_start_date": "20230804", "listing_expiration_date": "20261231"}